These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 29452503)

  • 1. ASCO 2007 Clinical Practice Guideline Update on the Role of Bisphosphonates in Multiple Myeloma: Guideline Summary.
    J Oncol Pract; 2007 Jul; 3(4):236. PubMed ID: 29452503
    [No Abstract]   [Full Text] [Related]  

  • 2. 2005 Update of ASCO Practice Guideline Recommendations for Colorectal Cancer Surveillance: Guideline Summary.
    J Oncol Pract; 2005 Nov; 1(4):137-139. PubMed ID: 29442584
    [No Abstract]   [Full Text] [Related]  

  • 3. 2006 Update of ASCO Practice Guideline Recommendations for the Use of White Blood Cell Growth Factors: Guideline Summary.
    J Oncol Pract; 2006 Jul; 2(4):196-201. PubMed ID: 29452013
    [No Abstract]   [Full Text] [Related]  

  • 4. 2007 Update of ASCO Practice Guideline for the Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: Guideline Summary.
    J Oncol Pract; 2007 May; 3(3):175-177. PubMed ID: 29455596
    [No Abstract]   [Full Text] [Related]  

  • 5. Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
    Bezjak A; Temin S; Franklin G; Giaccone G; Govindan R; Johnson ML; Rimner A; Schneider BJ; Strawn J; Azzoli CG
    J Clin Oncol; 2015 Jun; 33(18):2100-5. PubMed ID: 25944914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.
    Berenson JR; Hillner BE; Kyle RA; Anderson K; Lipton A; Yee GC; Biermann JS;
    J Clin Oncol; 2002 Sep; 20(17):3719-36. PubMed ID: 12202673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.
    Hillner BE; Ingle JN; Berenson JR; Janjan NA; Albain KS; Lipton A; Yee G; Biermann JS; Chlebowski RT; Pfister DG
    J Clin Oncol; 2000 Mar; 18(6):1378-91. PubMed ID: 10715310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology clinical practice guidelines: opportunities and challenges.
    Somerfield MR; Einhaus K; Hagerty KL; Brouwers MC; Seidenfeld J; Lyman GH;
    J Clin Oncol; 2008 Aug; 26(24):4022-6. PubMed ID: 18711193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update Summary.
    Taplitz RA; Kennedy EB; Flowers CR
    J Oncol Pract; 2018 Nov; 14(11):692-695. PubMed ID: 30179525
    [No Abstract]   [Full Text] [Related]  

  • 10. American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer.
    Basch EM; Somerfield MR; Beer TM; Carducci MA; Higano CS; Hussain MH; Scher HI;
    J Clin Oncol; 2007 Nov; 25(33):5313-8. PubMed ID: 17925542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Practice guidelines of the use of bisphosphonates in solid tumours with bone metastases and in multiple myeloma].
    Brantus JF; Roemer-Becuwe C; Cony-Makhoul P; Salino S; Fontana A; Debourdeau P; Thomas T; Guastalla JP; Ghesquieres H; Sebban C; Pavic M; Collet P; Larbre JP; Martinon S; Brocard F; Bodard AG; Blanc G; Balestrière V; Favier B; Farsi F; Krakowski I; Biron P;
    Rev Med Interne; 2011 Aug; 32(8):494-505. PubMed ID: 21376431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.
    Sulman EP; Ismaila N; Armstrong TS; Tsien C; Batchelor TT; Cloughesy T; Galanis E; Gilbert M; Gondi V; Lovely M; Mehta M; Mumber MP; Sloan A; Chang SM
    J Clin Oncol; 2017 Jan; 35(3):361-369. PubMed ID: 27893327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline.
    Rudin CM; Ismaila N; Hann CL; Malhotra N; Movsas B; Norris K; Pietanza MC; Ramalingam SS; Turrisi AT; Giaccone G
    J Clin Oncol; 2015 Dec; 33(34):4106-11. PubMed ID: 26351333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancers.
    Singh K; Tantravahi U; Lomme MM; Pasquariello T; Steinhoff M; Sung CJ
    Breast Cancer Res Treat; 2016 Jun; 157(3):405-11. PubMed ID: 27180259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2006 Update of the ASCO Recommendations for Antiemetics in Oncology: Guideline Summary.
    J Oncol Pract; 2006 Jul; 2(4):193-195. PubMed ID: 29452007
    [No Abstract]   [Full Text] [Related]  

  • 16. ASCO Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: Guideline Summary.
    J Oncol Pract; 2006 Sep; 2(5):258-261. PubMed ID: 29447032
    [No Abstract]   [Full Text] [Related]  

  • 17. HER2 FISH classification of equivocal HER2 IHC breast cancers with use of the 2013 ASCO/CAP practice guideline.
    Fan YS; Casas CE; Peng J; Watkins M; Fan L; Chapman J; Ikpatt OF; Gomez C; Zhao W; Reis IM
    Breast Cancer Res Treat; 2016 Feb; 155(3):457-62. PubMed ID: 26895325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
    Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
    Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ASCO experience with evidence-based clinical practice guidelines.
    Smith TJ; Somerfield MR
    Oncology (Williston Park); 1997 Nov; 11(11A):223-7. PubMed ID: 9430192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin use in oncology: a summary of the evidence and practice guidelines comparing efforts of the Cochrane Review group and Blue Cross/Blue Shield to set up the ASCO/ASH guidelines.
    Djulbegovic B
    Best Pract Res Clin Haematol; 2005; 18(3):455-66. PubMed ID: 15792920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.